TARO-DONEPEZIL TABLET
Negara: Kanada
Bahasa: Inggris
Sumber: Health Canada
Karakteristik produk
(SPC)
06-03-2020
Beberapa dokumen untuk produk ini saat ini tidak tersedia, Anda dapat mengirim permintaan ke layanan pelanggan kami dan kami akan memberi tahu Anda segera setelah kami bisa mendapatkannya.
Kirim permintaan.
Kirim permintaan.
Bahan aktif:
DONEPEZIL HYDROCHLORIDE
Tersedia dari:
SUN PHARMA CANADA INC
Kode ATC:
N06DA02
INN (Nama Internasional):
DONEPEZIL
Dosis:
10MG
Bentuk farmasi:
TABLET
Komposisi:
DONEPEZIL HYDROCHLORIDE 10MG
Rute administrasi :
ORAL
Unit dalam paket:
100/500
Jenis Resep:
Prescription
Area terapi:
PARASYMPATHOMEMETIC (CHOLINERGIC) AGENTS
Ringkasan produk:
Active ingredient group (AIG) number: 0131548002; AHFS:
Status otorisasi:
APPROVED
Tanggal Otorisasi:
2020-03-10
Karakteristik produk
Page 1 of 52
PRODUCT MONOGRAPH
PR
TARO-DONEPEZIL
Donepezil Hydrochloride Tablets, House Std
5 and 10 mg
CHOLINESTERASE INHIBITOR
Sun Pharma Canada Inc.
Date of Revision: March 6, 2020
126 East Drive
Brampton, Ontario
L6T 1C1
Submission Control No.: 236591
Page 2 of 52
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY PRODUCT INFORMATION
............................................................................
3
INDICATIONS AND CLINICAL USE
..................................................................................
3
CONTRAINDICATIONS
........................................................................................................
3
WARNINGS AND PRECAUTIONS
.......................................................................................
3
ADVERSE REACTIONS
.........................................................................................................
8
DRUG INTERACTIONS
.......................................................................................................
17
DOSAGE AND ADMINISTRATION
...................................................................................
18
OVERDOSAGE
......................................................................................................................
19
ACTION AND CLINICAL PHARMACOLOGY
............................................................... 20
STORAGE AND STABILITY
...............................................................................................
22
DOSAGE FORMS, COMPOSITION AND PACKAGING
................................................ 22
PART II: SCIENTIFIC INFORMATION
...............................................................................
24
PHARMACEUTICAL INFORMATION
.............................................................................
24
CLINICAL TRIALS
...............................................................................................................
25
DETAILED PHARMACOLOGY
..............
Baca dokumen lengkapnya
